Revvity vs PerkinElmer

Revvity and PerkinElmer are two companies operating in different sectors within the stock market. Revvity is a technology company specializing in software development, while PerkinElmer is a global leader in the life sciences and diagnostics industry. Both companies have shown strong performance in recent years, with Revvity experiencing rapid growth in the software sector and PerkinElmer benefiting from increased demand for healthcare solutions. Investors looking to diversify their portfolios may find opportunities in both Revvity and PerkinElmer stocks.

Revvity or PerkinElmer?

When comparing Revvity and PerkinElmer, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Revvity and PerkinElmer.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Revvity has a dividend yield of 0.23%, while PerkinElmer has a dividend yield of 0.22%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Revvity reports a 5-year dividend growth of 0.00% year and a payout ratio of 17.92%. On the other hand, PerkinElmer reports a 5-year dividend growth of 0.00% year and a payout ratio of 17.72%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Revvity P/E ratio at 79.41 and PerkinElmer's P/E ratio at 59.97. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Revvity P/B ratio is 1.95 while PerkinElmer's P/B ratio is 1.49.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Revvity has seen a 5-year revenue growth of -0.12%, while PerkinElmer's is -0.12%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Revvity's ROE at 2.47% and PerkinElmer's ROE at 2.50%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $123.52 for Revvity and $124.57 for PerkinElmer. Over the past year, Revvity's prices ranged from $79.50 to $128.15, with a yearly change of 61.19%. PerkinElmer's prices fluctuated between $79.50 and $138.90, with a yearly change of 74.72%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.